Financhill
Back

Bicara Therapeutics Quote, Financials, Valuation and Earnings

Bicara Therapeutics Price Quote

$18.00
-1.92 (-9.64%)
(Updated: December 12, 2024 at 5:55 PM ET)

Bicara Therapeutics Key Stats

Sell
25
Bicara Therapeutics (BCAX) is a Sell

Day range:
$18.89 - $20.44
52-week range:
$17.41 - $28.09
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%

Volume:
412.9K
Avg. volume:
325.3K
1-year change:
0%
Market cap:
$916.8M
Revenue:
$0
EPS:
$-0.2

How Much Does Bicara Therapeutics Make?

Data Unavailable

Is Bicara Therapeutics Growing As A Company?

Data Unavailable

Bicara Therapeutics Stock Price Performance

What Is Bicara Therapeutics 52-Week High & Low?

Bicara Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Bicara Therapeutics?

Is Bicara Therapeutics Cash Flow Positive?

  • What Is BCAX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$46.1M
  • What Is Bicara Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $235.5M
  • What Is Bicara Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$547K

Bicara Therapeutics Return On Invested Capital

Data Unavailable

Bicara Therapeutics Earnings Date & Stock Price

Bicara Therapeutics Competitors

Bicara Therapeutics Dividend Yield

Bicara Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -220%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 40.55
Upside from Last Price: 103.55%

Major Shareholders

  • How many BCAX shares are owned by institutional investors?
    51.5M BCAX shares are owned by institutional investors
  • How many BCAX shares are owned by insiders?
    766K BCAX shares are owned by insiders